Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ischemic injury triggers a protective microglial phenotype in models of Aβ pathology.

Journal of neuroinflammation·2026

Same author

Soluble epoxide hydrolase drives neurovascular dysfunction in a model of amyloidosis.

Brain : a journal of neurology·2026

Same author

Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.

Annals of neurology·2026

Same author

DNA methylation-based classification of hematolymphoid neoplasms.

Blood advances·2026

Same author

Glucose hypometabolism and hyperphosphorylated Tau synergistically drive neuronal necroptosis.

Neuron·2026

Same author

Type I interferon drives T cell responses to amyloid beta in the central nervous system.

Nature communications·2026

Search research articles

Related Experiment Video

Updated: May 12, 2026

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Fast-track neuropathological screening for neurodegenerative diseases.

Benjamin Englert^1,2, Sigrun Roeber¹, Thomas Arzberger^1,3

¹Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany.

Free Neuropathology

|August 9, 2024

Summary

A new fast-track brain autopsy method accurately diagnoses neurodegenerative diseases, including prion disease, in over 96% of cases. This speeds up preliminary diagnoses for physicians.

Keywords:

Alzheimer disease Dementia Lewy body disease Movement disorders Neuropathology Prion disease

More Related Videos

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Related Experiment Videos

Last Updated: May 12, 2026

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Area of Science:

Neuropathology
Neurodegenerative diseases
Prion disease diagnostics

Background:

Postmortem diagnosis of neurodegenerative diseases is resource-intensive.
Current methods require extensive brain sampling and histopathological evaluation.
Prion disease exclusion is a critical, time-consuming step.

Purpose of the Study:

To develop a fast-track histopathological procedure for prompt preliminary diagnosis.
To improve the efficiency of brain autopsy for suspected neurodegenerative disease.
To enable rapid feedback to clinicians regarding neuropathological findings.

Main Methods:

Screening of two brain regions (frontal cortex and cerebellum).
Utilized H&E staining and six immunohistochemical stains.
Compared fast-track diagnosis with final diagnosis in 133 brain donors.

Main Results:

Over 96% concordance between fast-track and final neuropathological diagnoses.
Identified four cases of prion disease without prior clinical suspicion.
Demonstrated reliability of the fast-track approach for initial diagnosis.

Conclusions:

The fast-track screening of two brain regions provides a reliable tentative diagnosis.
This method allows for prompt feedback to physicians for neurodegenerative disease cases.
Further comprehensive histological work-up is essential for accurate staging and co-pathology assessment.